Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bradykinin, Arg(0)-hyp(3)-phe(7)-
2. Bradykinin, Arg-hyp(3)-phe(7)-
3. Bradykinin, Arginyl-hydroxyprolyl(3)-phenylalanine(7)-
4. Npc 567
5. Npc-567
1. Npc-567
2. Npc 567
3. 109333-26-8
4. (d-arg0,hyp3,d-phe7)-bradykinin
5. Dv64b0pleh
6. Chembl446325
7. Chebi:73294
8. Arg(0)-hyp(3)-phe(7)-bradykinin
9. [d-arg(0),hyp(3),d-phe(7)]bradykinin
10. D-arg-arg-pro-hyp-gly-phe-ser-d-phe-phe-arg
11. D-arginyl-l-arginyl-l-prolyl-(4r)-4-hydroxy-l-prolylglycyl-l-phenylalanyl-l-seryl-d-phenylalanyl-l-phenylalanyl-l-arginine
12. Bradykinin, Arg-hyp(3)-phe(7)-
13. Unii-dv64b0pleh
14. Bradykinin, Arg(0)-hyp(3)-phe(7)-
15. Bradykinin, Arginyl-hydroxyprolyl(3)-phenylalanine(7)-
16. Gtpl676
17. D-arg-(hyp3,d-phe7)bradykinin
18. [d-arg0,hyp3,d-phe7]bradykinin
19. Bdbm50435301
20. Bim 31006
21. Bim-31006
22. Bradykinin, N2-d-arginyl-3-(trans-4-hydroxy-l-proline)-7-d-phenylalanine-
23. Q27088026
24. Bradykinin, N2-d-arginyl-3-((4r)-4-hydroxy-l-proline)-7-d-phenylalanine-
| Molecular Weight | 1282.5 g/mol |
|---|---|
| Molecular Formula | C60H87N19O13 |
| XLogP3 | -5.9 |
| Hydrogen Bond Donor Count | 17 |
| Hydrogen Bond Acceptor Count | 17 |
| Rotatable Bond Count | 36 |
| Exact Mass | 1281.67307391 g/mol |
| Monoisotopic Mass | 1281.67307391 g/mol |
| Topological Polar Surface Area | 541 Ų |
| Heavy Atom Count | 92 |
| Formal Charge | 0 |
| Complexity | 2550 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Analgesics
Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)
ABOUT THIS PAGE
A Arg-3-Hyp-7-Phe-Bradykinin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Arg-3-Hyp-7-Phe-Bradykinin, including repackagers and relabelers. The FDA regulates Arg-3-Hyp-7-Phe-Bradykinin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Arg-3-Hyp-7-Phe-Bradykinin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Arg-3-Hyp-7-Phe-Bradykinin supplier is an individual or a company that provides Arg-3-Hyp-7-Phe-Bradykinin active pharmaceutical ingredient (API) or Arg-3-Hyp-7-Phe-Bradykinin finished formulations upon request. The Arg-3-Hyp-7-Phe-Bradykinin suppliers may include Arg-3-Hyp-7-Phe-Bradykinin API manufacturers, exporters, distributors and traders.
click here to find a list of Arg-3-Hyp-7-Phe-Bradykinin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Arg-3-Hyp-7-Phe-Bradykinin DMF (Drug Master File) is a document detailing the whole manufacturing process of Arg-3-Hyp-7-Phe-Bradykinin active pharmaceutical ingredient (API) in detail. Different forms of Arg-3-Hyp-7-Phe-Bradykinin DMFs exist exist since differing nations have different regulations, such as Arg-3-Hyp-7-Phe-Bradykinin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Arg-3-Hyp-7-Phe-Bradykinin DMF submitted to regulatory agencies in the US is known as a USDMF. Arg-3-Hyp-7-Phe-Bradykinin USDMF includes data on Arg-3-Hyp-7-Phe-Bradykinin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Arg-3-Hyp-7-Phe-Bradykinin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Arg-3-Hyp-7-Phe-Bradykinin suppliers with USDMF on PharmaCompass.
Arg-3-Hyp-7-Phe-Bradykinin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Arg-3-Hyp-7-Phe-Bradykinin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Arg-3-Hyp-7-Phe-Bradykinin GMP manufacturer or Arg-3-Hyp-7-Phe-Bradykinin GMP API supplier for your needs.
A Arg-3-Hyp-7-Phe-Bradykinin CoA (Certificate of Analysis) is a formal document that attests to Arg-3-Hyp-7-Phe-Bradykinin's compliance with Arg-3-Hyp-7-Phe-Bradykinin specifications and serves as a tool for batch-level quality control.
Arg-3-Hyp-7-Phe-Bradykinin CoA mostly includes findings from lab analyses of a specific batch. For each Arg-3-Hyp-7-Phe-Bradykinin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Arg-3-Hyp-7-Phe-Bradykinin may be tested according to a variety of international standards, such as European Pharmacopoeia (Arg-3-Hyp-7-Phe-Bradykinin EP), Arg-3-Hyp-7-Phe-Bradykinin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Arg-3-Hyp-7-Phe-Bradykinin USP).
LOOKING FOR A SUPPLIER?
